当前位置:首页 - 行情中心 - 钱江生化(600796) - 财务分析 - 利润表

钱江生化

(600796)

  

流通市值:14.80亿  总市值:42.55亿
流通股本:3.01亿   总股本:8.67亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入1,328,333,633.25867,389,372.66357,819,300.482,008,864,542.47
营业收入1,328,333,633.25867,389,372.66357,819,300.482,008,864,542.47
二、营业总成本1,205,945,851.29804,314,304.06342,660,205.661,850,645,757.99
营业成本1,001,067,816.94666,626,041.97277,052,158.41,567,712,799.49
税金及附加9,389,863.566,732,858.352,353,152.7714,779,128.72
销售费用8,721,168.535,283,650.152,683,106.615,291,111.77
管理费用103,849,748.9469,824,258.2532,916,469.75134,859,088.39
研发费用22,226,502.8815,170,051.226,814,606.7131,451,632.93
财务费用60,690,750.4440,677,444.1220,840,711.4386,551,996.69
其中:利息费用63,683,370.939,787,393.5629,918,165.01102,253,372.14
其中:利息收入11,063,136.234,764,936.9-10,351,857.0214,994,175.81
加:投资收益40,511,062.9725,698,216.899,488,948.5755,342,567.96
资产处置收益9,462,174.579,431,902.6888,341.789,505,421.07
资产减值损失(新)-1,327,307.95-2,509,118.28263,041.21-4,585,337.32
信用减值损失(新)-14,023,921.8-2,916,146.61-2,213,824.04-1,940,673.8
其他收益11,929,227.717,190,520.553,629,654.6728,070,377.06
营业利润平衡项目0000
四、营业利润168,939,017.4699,970,443.8326,415,257.01244,611,139.45
加:营业外收入743,613.38101,585.898,552,391.281,396,666.38
减:营业外支出735,491.15658,641.02542,075.25,739,828.4
利润总额平衡项目0000
五、利润总额168,947,139.6999,413,388.734,425,573.09240,267,977.43
减:所得税费用41,789,272.8823,765,640.39,309,754.8150,172,397.46
六、净利润127,157,866.8175,647,748.425,115,818.28190,095,579.97
持续经营净利润127,157,866.8175,647,748.425,115,818.28190,095,579.97
归属于母公司股东的净利润139,602,979.5984,467,995.9730,338,975.13206,045,309.41
少数股东损益-12,445,112.78-8,820,247.57-5,223,156.86-15,949,729.44
(一)基本每股收益0.160.10.040.24
(二)稀释每股收益0.160.10.040.24
九、综合收益总额127,157,866.8175,647,748.425,115,818.28190,095,579.97
归属于母公司股东的综合收益总额139,602,979.5984,467,995.9730,338,975.13206,045,309.41
归属于少数股东的综合收益总额-12,445,112.78-8,820,247.57-5,223,156.86-15,949,729.44
公告日期2023-10-272023-08-252023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑